Richard Steinhart, the Chief Financial Officer of BioXcel, has executed a sale of company stock valued at $7,426. This transaction reflects his ongoing management of personal investment holdings. Details regarding the specific number of shares sold or the timing of the transaction were not disclosed.
Related Articles
Don't miss out on breaking stories and in-depth articles.